To that end, small molecules, which disrupt the HSP70-BAG3 interaction, were identified; these compounds revealed anti-proliferative activity in various cancer cells and were able to inhibit tumor growth in vivo (Colvin et al., 2014; Li et al., 2015; Antonietti et al., 2017). Here, BAG3 is linked to neoplasm.